Cargando…

A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity

The epidermal growth factor receptor (EGFR) is a member of the human epidermal growth factor receptor (HER) family of receptor tyrosine kinases; it is a transmembrane receptor involved in cell growth and differentiation. EGFR homodimers or heterodimers in combination with other HER members, such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takei, Junko, Kaneko, Mika Kato, Ohishi, Tomokazu, Kawada, Manabu, Harada, Hiroyuki, Kato, Yukinari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068343/ https://www.ncbi.nlm.nih.gov/pubmed/32218834 http://dx.doi.org/10.3892/ol.2020.11384

Ejemplares similares

H(2)Mab-19, an anti-human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts
por: Takei, Junko, et al.
Publicado: (2020)

A defucosylated anti-PD-L1 monoclonal antibody 13-mG(2a)-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma
por: Takei, Junko, et al.
Publicado: (2020)

Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma
por: Itai, Shunsuke, et al.
Publicado: (2018)

Anti-EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas
por: Kaneko, Mika K., et al.
Publicado: (2020)

Anti-HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma
por: Asano, Teizo, et al.
Publicado: (2021)

An anti-TROP2 monoclonal antibody TrMab-6 exerts antitumor activity in breast cancer mouse xenograft models
por: Tanaka, Tomohiro, et al.
Publicado: (2021)

The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma
por: Hosono, Hideki, et al.
Publicado: (2020)

A cancer-specific anti-podocalyxin monoclonal antibody (60-mG(2a)-f) exerts antitumor effects in mouse xenograft models of pancreatic carcinoma
por: Kaneko, Mika K., et al.
Publicado: (2020)

Defucosylated Mouse–Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors
por: Li, Guanjie, et al.
Publicado: (2021)

Anti-EGFR monoclonal antibody 134-mG(2a) exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma
por: Hosono, Hideki, et al.
Publicado: (2020)

A defucosylated anti-CD44 monoclonal antibody 5-mG(2a)-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma
por: Takei, Junko, et al.
Publicado: (2020)

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134
por: Kaneko, Mika K., et al.
Publicado: (2018)

Antibody–Drug Conjugates Using Mouse–Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model
por: Kato, Yukinari, et al.
Publicado: (2020)

Defucosylated Monoclonal Antibody (H(2)Mab-139-mG(2a)-f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)

The mouse–canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models
por: Kato, Yukinari, et al.
Publicado: (2018)

Defucosylated mouse-dog chimeric anti-HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG(2a)-f) Exerts Antitumor Activity in Xenograft Model
por: Asano, Teizo, et al.
Publicado: (2022)

A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)

Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity
por: Itai, Shunsuke, et al.
Publicado: (2017)

Antitumor activities of a defucosylated anti-EpCAM monoclonal antibody in colorectal carcinoma xenograft models
por: Li, Guanjie, et al.
Publicado: (2023)

Development of EMab-51, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Flow Cytometry, Western Blot, and Immunohistochemistry
por: Itai, Shunsuke, et al.
Publicado: (2017)

Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma
por: Tateyama, Nami, et al.
Publicado: (2022)

Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation
por: Ohishi, Tomokazu, et al.
Publicado: (2020)

Antitumor activity of chLpMab‐2, a human–mouse chimeric cancer‐specific antihuman podoplanin antibody, via antibody‐dependent cellular cytotoxicity
por: Kaneko, Mika K., et al.
Publicado: (2017)

Anti-Thy-1 Antibody-mediated Complement-dependent Cytotoxicity is Regulated by the Distribution of Antigen, Antibody and Membrane Complement Regulatory Proteins in Rats
por: Kato, Chie, et al.
Publicado: (2013)

Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
por: Price, M. R., et al.
Publicado: (1982)

EMab-300 Detects Mouse Epidermal Growth Factor Receptor-Expressing Cancer Cell Lines in Flow Cytometry
por: Goto, Nohara, et al.
Publicado: (2023)

Development of an anti-bear podoplanin monoclonal antibody PMab-247 for immunohistochemical analysis
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Current Targeted Therapy for Metastatic Colorectal Cancer
por: Ohishi, Tomokazu, et al.
Publicado: (2023)

A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity
por: Youk, Hee-Jeong, et al.
Publicado: (2022)

Establishment of a monoclonal antibody PMab-225 against alpaca podoplanin for immunohistochemical analyses
por: Kato, Yukinari, et al.
Publicado: (2019)

INTRARENAL COMPLEMENT FIXATION BY CYTOTOXIC ANTIBODIES
por: Sellin, D., et al.
Publicado: (1970)

Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Influenza and Antibody-Dependent Cellular Cytotoxicity
por: Von Holle, Tarra A., et al.
Publicado: (2019)

Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysis
por: Sayama, Yusuke, et al.
Publicado: (2021)

Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
por: Machitani, Mitsuhiro, et al.
Publicado: (2022)

A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2014)

Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays
Publicado: (1989)

Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity
por: Gupta, Nimesh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tneordkenlh561nq7cehi6svrr